Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Are psychotropic drugs at therapeutic levels a concern for cardiologists?

Burggraf GW.

Can J Cardiol. 1997 Jan;13(1):75-80. Review.

PMID:
9039069
2.

Catastrophic consequences secondary to psychotropic drugs, Part 1.

Keltner NL.

J Psychosoc Nurs Ment Health Serv. 1997 Apr;35(4):41-5. Review.

PMID:
9109064
3.

Neurotropic and psychotropic drugs in dermatology.

Tennyson H, Levine N.

Dermatol Clin. 2001 Jan;19(1):179-97, x. Review.

PMID:
11155582
4.

Cardiac effects of psychotropic drugs.

Chong SA, Mythily, Mahendran R.

Ann Acad Med Singapore. 2001 Nov;30(6):625-31. Review.

PMID:
11817292
5.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

6.

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.

Williams JW Jr, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J.

Ann Intern Med. 2000 May 2;132(9):743-56. Review.

PMID:
10787370
7.

Induction of obesity by psychotropic drugs.

Bernstein JG.

Ann N Y Acad Sci. 1987;499:203-15. Review.

PMID:
2886102
8.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

9.

Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.

Lee KC, Finley PR, Alldredge BK.

Expert Opin Drug Saf. 2003 May;2(3):233-47. Review.

PMID:
12904103
10.

Review of the cardiovascular effects of heterocyclic antidepressants.

Glassman AH, Preud'homme XA.

J Clin Psychiatry. 1993 Feb;54 Suppl:16-22. Review.

PMID:
8444830
11.
12.

St. John's wort: a new alternative for depression?

Josey ES, Tackett RL.

Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.

PMID:
10190758
13.

Cardiac side effects of psychiatric drugs.

Mackin P.

Hum Psychopharmacol. 2008 Jan;23 Suppl 1:3-14. Review.

PMID:
18098218
14.

The cardiovascular effects of antidepressants.

Warrington SJ, Padgham C, Lader M.

Psychol Med Monogr Suppl. 1989;16:i-iii, 1-40. Review.

PMID:
2690161
15.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
16.

Novel psychotropic medications in children: new toxicities to master.

Jacobs ES, Dickstein DP, Liebelt EL.

Pediatr Emerg Care. 2001 Jun;17(3):226-31. Review. No abstract available.

PMID:
11437154
17.

Medically serious adverse effects of newer antidepressants.

Mago R, Mahajan R, Thase ME.

Curr Psychiatry Rep. 2008 Jun;10(3):249-57. Review.

PMID:
18652794
18.

[The patient under antidepressive and antipsychotic therapy].

Hummel J, Lederbogen F.

MMW Fortschr Med. 2006 May 15;Spec no. 2:11-5; quiz 16. Review. German.

PMID:
20104708
19.

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review.

Lane R, Baldwin D.

J Clin Psychopharmacol. 1997 Jun;17(3):208-21. Review.

PMID:
9169967
20.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718

Supplemental Content

Support Center